SEARCH

SEARCH BY CITATION

References

  • 1
    O'Connor AM, Rostom A, Fiset V et al. Decision aids for patients facing health treatment or screening decisions: systematic review. Br Med J 1999;731734.
  • 2
    Feldman-Stewart D, Brennenstuhl S, McIssac K et al. A systematic review of information in decision aids. Health Expect 2007;10(1):4661.
  • 3
    O'Connor AM. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst 1999;25:6780.
  • 4
    O'Connor AM, Stacey D, Entwistle V et al. Decision aids for people facing health treatment or screening decisions [update of Cochrane Database Syst Rev. 2001;(3)]. Cochrane Database Syst Rev 2003;2.
  • 5
    Wakefield C, Meiser B, Homewood J et al. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns 2007;16(3):325339.
  • 6
    van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer 2004;90(2):333342.
  • 7
    van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. J Clin Oncol 2004;22(16):32933301.
  • 8
    Green MJ, Peterson SK, Baker MW et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med 2005;7(4):221229.
  • 9
    Green MJ, Peterson SK, Baker MW et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. J Am Med Assoc 2004;292(4):442452.
  • 10
    Schwartz M, Benkendorf JL, Lerman C, Isaacs C, Ryan-Roberston A, Johnson L. Impact of educational print materials on knowledge, attitudes and interest in BRCA1/BRCA2 testing among Ashkenazi Jewish women. Cancer 2001;92(4):932940.
  • 11
    Schwartz M, Valdimarsdottir H, DeMarco T, Lawrence W, Peshkin B. A randomized trial of a decision aid for BRCA1/2 mutation carriers. Psycho-Oncology 2007;16(9 Suppl):S21.
  • 12
    Lerman C, Biesecker B, Benkendorf JL et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89(2):148157.
  • 13
    Thewes B, Meiser B, Taylor A et al. The fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 2005;23(22):51555165.
  • 14
    O'Connor A, Tugwell P, Welles GA et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventative hormone replacement therapy. Med Decis Making 1998;18:295303.
  • 15
    Elwyn G, O'Connor A, Stacey D et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Br Med J 2006;333(7565):417.
  • 16
    Wakefield C, Meiser B, Homewood J et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat 2008;107:289301.
  • 17
    O'Cathain A, Thomas K. Evaluating decision aids—where next? Health Expect 2004;7:98103.
  • 18
    Australian Cancer Network. Guidelines on Familial Aspects of Cancer. Australian Cancer Network: Sydney, 1999.
  • 19
    National Breast Cancer Centre. Current Best Advice About Familial Aspects of Breast/Ovarian Cancer. NHMRC National Breast Cancer Centre: Sydney, 2000.
  • 20
    Centre for Genetics Education. Centre for genetics education web site 〈http://www.genetics.com.au/〉. Accessed January 19, 2007. NSW Health, 2007.
  • 21
    O'Connor AM, Stacey D, Entwistle V et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2006;1:1.
  • 22
    O'Connor AM. Validation of a Decisional Conflict Scale. Med Decis Making 1995;15(1):2530.
  • 23
    Ottawa Health Decision Centre at the Ottawa Health Research Institute. User Manual—Decisional Conflict Scale(s) 〈http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_DecConflict2006.pdf〉. Accessed. University of Ottawa, 2006.
  • 24
    Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002;48(1):8791.
  • 25
    Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979;41:209218.
  • 26
    Thewes B, Meiser B, Hickie IB et al. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 2001;10(6):459468.
  • 27
    Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Psychiatr Scand 1983;67:361.
  • 28
    Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994;30A(1):3740.
  • 29
    Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000;48:579584.
  • 30
    Brehaut JC, O'Connor AM, Wood TJ et al. Validation of a Decision Regret Scale. Med Decis Making 2003;23(4):281292.
  • 31
    SPSS Inc. Statistical Program for the Social Sciences: Release 14.0. SPSS Inc.: Chicago, IL, 2005.
  • 32
    StataCorp. Stata Statistical Software: Release 9.0. StataCorp: College Station, TX, 2005.
  • 33
    Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645646.
  • 34
    Cohen J. Statistical Power Analysis for the Behavioural Sciences (2nd edn). Academic Press: New York: 1988.
  • 35
    Norman G, Sloan J, Wyrwich K. Interpretation of changes in health-related quality of life. Med Care 2003;41(5):562582.
  • 36
    Mireskandari S, Meiser B, Sherman K, Warner BJ, Andrews L, Tucker KM. Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer. Psycho-Oncology 2006;15(2):96108.
  • 37
    Manne S, Audrain J, Schwartz M, Main D, Finch C, Lerman C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 2004;28(3):211225.
  • 38
    Bekker HL, Legare F, Stacey D, O'Connor A, Lemyre L. Is anxiety a suitable measure of decision aid effectiveness: a systematic review? Patient Educ Couns 2003/7;50(3):255262.
  • 39
    Rowe HJ, Fisher JR, Quinlivan JA. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice [see comment]. Aust N Z J Obstet Gynaecol 2006;46(5):433439.
  • 40
    Kasparian NA, Wakefield CE, Meiser B. Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns 2007;16(6):693712.
  • 41
    O'Donnell S, Cranney A, Jacobsen MJ, Graham ID, O'Connor AM, Tugwell P. Understanding and overcoming the barriers of implementing patient decision aids in clinical practice. J Eval Clin Pract 2006;12(2):174181.
  • 42
    Silvia KA, Sepucha KR. Decision aids in routine practice: lessons from the breast cancer initiative. Health Expect 2006;9(3):255264.
  • 43
    Charles C, Gafni A, Whelan T et al. Treatment decision aids: conceptual issues and future directions. Health Expect 2005;8(2):114125.
  • 44
    Australian Bureau of Statistics. Australian Social Trends 2006. Australian Bureau of Statistics: Canberra, 2006.